$KAST just announced a Joint Venture Agreement with Dakota Life Sciences to develop, fund, and market Site Specific Penetration Technology (SSPT) biopharmaceutical products. http://www.bullishguru.com/kast-offers-a-tactical-opportunity-in-strong-biopharma-trend/